A Turning Point in the Fight Against Cancer: European Mortality Rates Projected to Fall as Female Lung Cancer Stabilizes

Tuesday, January 20, 2026

BRUSSELS — In a landmark analysis of European health trends, researchers are projecting a significant decline in cancer mortality rates across the European Union by the end of 2026. While the absolute number of cancer deaths is expected to rise due to an aging population, the rate at which people are dying from the disease is falling—marking a pivotal moment in public health, particularly as the decades-long rise in female lung cancer deaths finally shows signs of stabilization.

The study, published in Annals of Oncology, predicts that age-standardized cancer mortality rates will drop by 7.8% in men and 5.9% in women compared to the 2020–2022 period. This downward trend is a testament to decades of tobacco control, earlier screenings, and therapeutic breakthroughs. However, the data reveals a complex landscape where progress is unevenly distributed across age groups and regions.

The Shifting Landscape of Lung Cancer

For decades, lung cancer has remained the leading cause of cancer-related mortality in Europe. While male mortality rates have been steadily declining since the 1990s—reflecting a shift in smoking habits that began decades ago—women have not shared the same trajectory. Until now.

The new projections suggest that female lung cancer mortality is finally leveling off at approximately 12.5 deaths per 100,000 women across most of the EU.

“We are seeing a historic plateau,” says Dr. Carlo La Vecchia, lead author of the study and Professor at the University of Milan. “For years, the ‘tobacco epidemic’ among women lagged behind men. We are now seeing the first real evidence that this curve is flattening, though the work is far from over.”

A Tale of Two Generations

The data highlights a stark generational divide. The decline in female lung cancer mortality is almost exclusively confined to women under the age of 65. Among older age groups, mortality rates continue to show unfavorable trends.

Medical experts suggest this is due to the “cohort effect”—younger generations of women have had lower smoking rates or have quit earlier in life compared to those born in the mid-20th century.

By the Numbers: 2026 Projections

Despite the falling rates, the researchers estimate that approximately 1,230,000 people will die from cancer in the EU in 2026. This increase in absolute numbers is attributed to the “graying” of Europe; as the population lives longer, the total number of individuals at risk for cancer increases.

Data source: Annals of Oncology (La Vecchia et al., 2026)

The study also highlights a staggering success story: since the peak of cancer mortality in 1988, an estimated 7.3 million deaths have been averted in the EU thanks to medical and policy interventions.

Expert Insights: Beyond the Data

While the report is largely optimistic, independent experts warn against complacency. The stabilization of lung cancer in women is not universal; Spain, for instance, is projected to see a 2.4% increase in female lung cancer mortality, bucking the general EU trend.

“These findings are a double-edged sword,” says Dr. Elena Rossi, a Brussels-based oncologist not involved in the study. “While we celebrate the stabilization in women, the fact that lung cancer remains our top killer—and that rates are still rising in older women—means our prevention strategies must be more targeted.”

Dr. Rossi emphasizes that the decline in mortality isn’t just about fewer people smoking. “We are seeing the impact of low-dose CT screening for high-risk individuals and the arrival of targeted therapies and immunotherapies that have turned once-terminal diagnoses into manageable chronic conditions for many.”

The Path Forward: Public Health Implications

The researchers are clear: the progress made so far is a direct result of policy. To maintain this momentum, the study authors call for a “four-pillar” approach to tobacco control:

1. Strengthening taxation on tobacco and nicotine products.

2. Strict advertising bans to prevent youth uptake.

3. Expanding smoke-free environments to de-normalize smoking.

4. Robust cessation support for current smokers.

“Closing the regional and socioeconomic gaps is essential,” the authors note, pointing out that lower-income populations often bear a disproportionate burden of cancer mortality.

What This Means for You

For the average citizen, these statistics underscore two vital actions:

• Prevention: If you smoke, it is never too late to quit. The “averted deaths” cited in the study are largely people who stopped smoking in middle age.

• Screening: Early detection remains the most effective way to improve survival. Discuss lung cancer screening with your physician if you have a significant smoking history, even if you feel healthy.

Limitations of the Study

While the study utilizes high-quality data from the World Health Organization (WHO) and the United Nations, it relies on “joinpoint” linear regression models. These models assume that current trends will continue in a straight line for the next few years. They may not account for sudden shifts, such as new environmental factors, the long-term impact of COVID-19 on cancer screenings, or sudden breakthroughs in medical technology that could accelerate the decline.

References

• https://www.medscape.com/viewarticle/female-lung-cancer-mortality-may-be-stabilizing-and-cancer-2026a10001ju

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.